Paradigm Biopharmaceuticals Ltd
OTC:PBIGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Paradigm Biopharmaceuticals Ltd
OTC:PBIGF
|
AU |
|
P
|
Proto Labs Inc
XMUN:PRZ
|
US |
|
3
|
3M Co
F:MMM
|
US |
Shareholder Yield
Current shareholder yield for
PBIGF is
.
Peers Comparison
Shareholder Yield
Price Appreciation
PBIGF Price
Paradigm Biopharmaceuticals Ltd
| Average Annual Return | -29.83% |
| Standard Deviation of Annual Returns | 30.98% |
| Max Drawdown | -93% |
| Market Capitalization | 72.8m USD |
| Shares Outstanding | 350 364 000 |
| Percentage of Shares Shorted |
N/A
|
PBIGF Return Decomposition
Main factors of price return
Stock Splits
PBIGF's latest stock split occurred on Nov 1, 2023
The company executed a 257-for-250 stock split, meaning that for every 250 shares held, investors received 257 new shares.
Before the split, PBIGF traded at 0.4345 per share. Afterward, the share price was about 0.43.
The adjusted shares began trading on Nov 1, 2023. This was the only stock split in PBIGF's history.